HDAC9 and Merkel cell skin cancer: We confirmed these synergistic effects in the MCC cell lines: Treatment with mithramycin A alone already reduced transcription of most class I and II HDAC genes in MCC cell lines and, most importantly, mithramycin A prevented the regulatory induction of HDACs by vorinostat (Supplementary Fig. 6).